Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Andrew Emerson

Andrew Emerson is recorded as CFO at Idexx Laboratories Inc /De (IDXX). Idexx Laboratories Inc /De reported in an 8-K filed November 21, 2024 that Andrew Emerson was appointed Executive Vice President, Chief Financial Officer and Treasurer, effective March 1, 2025. The proxy statement of Idexx Laboratories Inc /De reports total compensation of $3,033,071 for Andrew Emerson in fiscal 2025, including a base salary of $531,146. Andrew Emerson has spoken on 6 earnings calls across 1 company, most recently for Idexx Laboratories Inc /De on August 4, 2026.

“On November 20, 2024, the Board appointed Andrew Emerson, currently Senior Vice President, Corporate and Companion Animal Group (“CAG”) Finance of the Company, as Executive Vice President, Chief Financial Officer and Treasurer of the Company, effective March 1, 2025.”
Idexx Laboratories Inc /De Form 8-K, filed November 21, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Idexx Laboratories Inc /De

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Idexx Laboratories Inc /De (IDXX) $531,146 $3,033,071

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.